Empyrean Capital Partners’s Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant FACA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-850,000
Closed -$8.83M 216
2021
Q2
$8.83M Hold
850,000
0.2% 112
2021
Q1
$8.6M Buy
+850,000
New +$8.94M 0.25% 101

Other funds holding FACA.U

Empyrean Capital Partners's FACA.U Position: Q3 2021 in Review

Empyrean Capital Partners sold out of Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant (FACA.U) in Q3 2021, closing a stake of 850,000 shares — an estimated $8.83M sold.

Empyrean Capital Partners first reported a position in FACA.U in Q1 2021 and held it in 2 quarters. The position peaked at $8.83M in Q2 2021. 35 funds tracked by Wall St. Rank hold FACA.U as of Q3 2021.

  • Empyrean Capital Partners reported no remaining Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant position as of Q3 2021 after selling out during the quarter.
  • Empyrean Capital Partners sold 850,000 Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant shares in Q3 2021, an estimated $8.83M.
  • Empyrean Capital Partners first reported a position in Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant in Q1 2021 and held it in 2 quarters.
  • Empyrean Capital Partners's Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant position peaked at $8.83M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant as of Q3 2021.

Based on Empyrean Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.